Cybin Files an International Patent Application Covering Psychedelic Delivery Methods
Cybin Inc. (CYBN) developed a new device that delivers psychedelic medicine through inhalation.
Inhaling psychedelics could be superior to oral administration, as it could result in optimized session timing, lower doses, and greater control for healthcare providers.
The company filed an international patent application for the method and the device, which has potential to gain coverage in 153 countries.